Home Cart 0 Sign in  
X

[ CAS No. 16498-81-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 16498-81-0
Chemical Structure| 16498-81-0
Chemical Structure| 16498-81-0
Structure of 16498-81-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 16498-81-0 ]

Related Doc. of [ 16498-81-0 ]

Alternatived Products of [ 16498-81-0 ]

Product Details of [ 16498-81-0 ]

CAS No. :16498-81-0 MDL No. :MFCD00085110
Formula : C7H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :FTEZJSXSARPZHJ-UHFFFAOYSA-N
M.W : 153.14 Pubchem ID :708093
Synonyms :

Calculated chemistry of [ 16498-81-0 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.69
TPSA : 59.42 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.75 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.94
Log Po/w (XLOGP3) : 0.68
Log Po/w (WLOGP) : 0.79
Log Po/w (MLOGP) : -0.96
Log Po/w (SILICOS-IT) : 0.71
Consensus Log Po/w : 0.43

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.49
Solubility : 4.96 mg/ml ; 0.0324 mol/l
Class : Very soluble
Log S (Ali) : -1.5
Solubility : 4.79 mg/ml ; 0.0313 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.51
Solubility : 4.73 mg/ml ; 0.0309 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.49

Safety of [ 16498-81-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 16498-81-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16498-81-0 ]
  • Downstream synthetic route of [ 16498-81-0 ]

[ 16498-81-0 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 67-56-1 ]
  • [ 16498-81-0 ]
  • [ 67367-26-4 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: for 6 h; Reflux
Stage #2: With sodium hydrogencarbonate In water
PREPARATION 47 2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-amine [Show Image]a) methyl 2-methoxynicotinate Concentrated aqueous sulphuric acid (0.1 mL) was added to a solution of 2-methoxynicotinic acid (2.00 g, 13.1 mmol) in methanol (20 mL) and the mixture was stirred and heated to reflux. After 6 hours, a saturated aqueous solution of sodium hydrogen carbonate was added and the mixture was extracted with ethyl acetate. The organic layer was dried (MgSO4 and concentrated to give the title compound (1.85 g, 85percent) as a colourless oil. LRMS (m/z): 168 (M+1)+.1H NMR (300 MHz, DMSO-d6) δ ppm 3.81 (s, 3H), 3.92 (s, 3H), 7.11 (dd, 1H), 8.13 (dd, 1H), 8.38(dd, 1H).
85%
Stage #1: for 6 h; Reflux
Stage #2: With sodium hydrogencarbonate In water
PREPARATION 47 2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-amine a) methyl 2-methoxynicotinate Concentrated aqueous sulphuric acid (0.1 mL) was added to a solution of 2-methoxynicotinic acid (2.00 g, 13.1 mmol) in methanol (20 mL) and the mixture was stirred and heated to reflux. After 6 hours, a saturated aqueous solution of sodium hydrogen carbonate was added and the mixture was extracted with ethyl acetate. The organic layer was dried (MgSO4 and concentrated to give the title compound (1.85 g, 85percent) as a colourless oil. LRMS (m/z): 168 (M+1)+.1H NMR (300 MHz, DMSO-d6) δ ppm 3.81 (s, 3H), 3.92 (s, 3H), 7.11 (dd, 1H), 8.13 (dd, 1H), 8.38(dd, 1H).
Reference: [1] Patent: EP2397482, 2011, A1, . Location in patent: Page/Page column 64
[2] Patent: WO2011/157397, 2011, A1, . Location in patent: Page/Page column 119
  • 2
  • [ 16498-81-0 ]
  • [ 18107-18-1 ]
  • [ 67367-26-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 18, p. 3386 - 3399
  • 3
  • [ 16498-81-0 ]
  • [ 54916-66-4 ]
YieldReaction ConditionsOperation in experiment
82% With bromine In water at 20℃; To a solution of 2-methoxynicotinic acid (20 g, 130.60 mmol) in H20 (1500 mL), Br2 (20 mL, 375.45 mmol) was added at room temperature. The mixture was stirred at room temperature overnight. The reaction mixture was filtered, washed with water and dried to provide 5-bromo-2-methoxynicotinic acid (25 g, yield: 82percent). 1H- MR (DMSO, 400 MHz) δ 13.33 (br s, 1H), 8.47 (d, J= 2.4 Hz, 1H), 8.21 (d, J= 2.4 Hz, 1H), 3.90 (s, 3H). MS (M+H)+: 232 / 234.
82% With bromine In water at 20℃; Step 1-Synthesis of 5-bromo-2-methoxynicotinic acid
To a solution of 2-methoxynicotinic acid (20 g, 130.60 mmol) in H2O (1500 mL), Br2 (20 mL, 375.45 mmol) was added at room temperature.
The mixture was stirred at room temperature overnight.
The reaction mixture was filtered, washed with water and dried to provide 5-bromo-2-methoxynicotinic acid (25 g, yield: 82percent).
1H-NMR (DMSO, 400 MHz) δ 13.33 (br s, 1H), 8.47 (d, J=2.4 Hz, 1H), 8.21 (d, J=2.4 Hz, 1H), 3.90 (s, 3H). MS (M+H)+: 232/234.
Reference: [1] Patent: WO2013/33971, 2013, A1, . Location in patent: Page/Page column 144
[2] Patent: US2014/213571, 2014, A1, . Location in patent: Paragraph 0572
  • 4
  • [ 2942-59-8 ]
  • [ 16498-81-0 ]
Reference: [1] Patent: US4342771, 1982, A,
  • 5
  • [ 67367-26-4 ]
  • [ 16498-81-0 ]
Reference: [1] Patent: WO2011/8247, 2011, A1, . Location in patent: Page/Page column 215-216
  • 6
  • [ 2942-59-8 ]
  • [ 124-41-4 ]
  • [ 16498-81-0 ]
Reference: [1] Synthetic Communications, 1989, vol. 19, # 9-10, p. 1505 - 1508
  • 7
  • [ 16498-81-0 ]
  • [ 54916-65-3 ]
YieldReaction ConditionsOperation in experiment
52% With hydrogenchloride In aqueous sodium hypochlorite EXAMPLE 1
A 306 mg. (0.002 mole) sample of 2-methoxynicotinic acid (the product of Preparation A) was added in one portion to 20 ml. of well-stirred 5.25percent aqueous sodium hypochlorite solution (Clorox).
The resulting mixture (now a solution) was then allowed to stir at room temperature (~20° C.) for a period of approximately 18 hours (i.e., overnight).
Upon completion of this step, the reaction mixture was acidified with 10 ml. of 1N hydrochloric acid and the resulting precipitate was subsequently extracted with chloroform.
The organic extracts were then combined, dried over anhydrous magnesium sulfate and filtered, and the resulting filtrate was subsequently concentrated in vacuo to afford 195 mg. (52percent) of pure 5-chloro-2-methoxynicotinic acid, m.p. 139°-141° C. (literature m.p. 149°-150° C., according to D. E.
Kuhla et al. in U.S. Pat. No. 3,879,403).
The pure product was further characterized by means of nuclear magnetic resonance data and mass spectroscopy.
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 7, p. 1859 - 1865
[2] Synthetic Communications, 1989, vol. 19, # 9-10, p. 1505 - 1508
[3] Patent: US4980357, 1990, A,
[4] Patent: US4716231, 1987, A,
[5] Patent: EP306251, 1990, A3,
[6] Patent: EP306251, , A2, [6] Patent: , 1989, ,
  • 8
  • [ 16498-81-0 ]
  • [ 13472-59-8 ]
Reference: [1] Chemical Science, 2018, vol. 9, # 15, p. 3860 - 3865
  • 9
  • [ 16498-81-0 ]
  • [ 131674-40-3 ]
Reference: [1] Patent: EP2287173, 2011, A1,
[2] Patent: WO2014/151142, 2014, A1,
  • 10
  • [ 16498-81-0 ]
  • [ 112197-16-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 18, p. 3386 - 3399
[2] Patent: WO2012/27261, 2012, A1, . Location in patent: Page/Page column 571; 572
  • 11
  • [ 16498-81-0 ]
  • [ 112197-15-6 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 33, p. 11527 - 11536
  • 12
  • [ 16498-81-0 ]
  • [ 67-64-1 ]
  • [ 145887-88-3 ]
  • [ 285991-71-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 22, p. 3811 - 3813
  • 13
  • [ 16498-81-0 ]
  • [ 942060-13-1 ]
Reference: [1] Patent: WO2012/27261, 2012, A1,
  • 14
  • [ 16498-81-0 ]
  • [ 1256811-02-5 ]
Reference: [1] Patent: US2014/213571, 2014, A1,
[2] Patent: WO2013/33971, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 16498-81-0 ]

Ethers

Chemical Structure| 67367-26-4

[ 67367-26-4 ]

Methyl 2-methoxynicotinate

Similarity: 0.95

Chemical Structure| 1060806-77-0

[ 1060806-77-0 ]

6-Amino-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 1060806-62-3

[ 1060806-62-3 ]

6-Bromo-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 884494-82-0

[ 884494-82-0 ]

5-Fluoro-2-methoxynicotinic acid

Similarity: 0.86

Chemical Structure| 1211581-22-4

[ 1211581-22-4 ]

2-Methoxy-3-methylisonicotinic acid

Similarity: 0.86

Carboxylic Acids

Chemical Structure| 1060806-77-0

[ 1060806-77-0 ]

6-Amino-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 1060806-62-3

[ 1060806-62-3 ]

6-Bromo-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 884494-82-0

[ 884494-82-0 ]

5-Fluoro-2-methoxynicotinic acid

Similarity: 0.86

Chemical Structure| 1211581-22-4

[ 1211581-22-4 ]

2-Methoxy-3-methylisonicotinic acid

Similarity: 0.86

Chemical Structure| 54916-66-4

[ 54916-66-4 ]

5-Bromo-2-methoxynicotinic acid

Similarity: 0.85

Related Parent Nucleus of
[ 16498-81-0 ]

Pyridines

Chemical Structure| 67367-26-4

[ 67367-26-4 ]

Methyl 2-methoxynicotinate

Similarity: 0.95

Chemical Structure| 67383-31-7

[ 67383-31-7 ]

Methyl 2-hydroxynicotinate

Similarity: 0.89

Chemical Structure| 1060806-77-0

[ 1060806-77-0 ]

6-Amino-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 1060806-62-3

[ 1060806-62-3 ]

6-Bromo-2-methoxynicotinic acid

Similarity: 0.87

Chemical Structure| 884494-82-0

[ 884494-82-0 ]

5-Fluoro-2-methoxynicotinic acid

Similarity: 0.86